Passa al contenuto
Merck
  • Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide.

Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide.

Acta crystallographica. Section F, Structural biology and crystallization communications (2006-06-07)
D P Marchi-Salvador, C A H Fernandes, S F Amui, A M Soares, M R M Fontes
ABSTRACT

For the first time, a non-catalytic and myotoxic Lys49-PLA2 (BthTX-I from Bothrops jararacussu venom) has been crystallized with BPB inhibitor. X-ray diffraction data were collected and electron-density calculations showed that the ligand is bound to the His48 residue. BthTX-I with His48 chemically modified by BPB shows strongly reduced myotoxic and cytotoxic activities. This suggests a biological correlation between the modification of His48, which is associated with catalytic activity of PLA2s, and other toxicological activities of Lys49-PLA2s.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
2,4′-Dibromoacetophenone, >98%
Supelco
2,4′-Dibromoacetophenone, for HPLC derivatization, LiChropur, ≥99.0% (HPLC)